Why it was recalled
Defective Delivery System: customer complaints exceeded respective action limits.
Product description
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3
Lot numbers, UPCs & expiration codes
Lot: 90764 Exp. 08/2022
Where it was sold
Nationwide to the U.S. Market
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0889-2022
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- May 6, 2022
- FDA report date
- Jun 1, 2022
- Quantity
- 274, 110 patches
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Noven Pharmaceuticals Inc
Original FDA data
Every field from FDA enforcement report D-0889-2022, exactly as published.
Show all FDA fields
- City
- Miami
- State
- FL
- Status
- Ongoing
- Country
- United States
- Event ID
- 90162
- Address
- 11960 Sw 144th St
- Code information
- Lot: 90764 Exp. 08/2022
- Postal code
- 33186-6109
- Report date
- Jun 1, 2022
- Product type
- Drugs
- Recall number
- D-0889-2022
- Classification
- Class II
- Recalling firm
- Noven Pharmaceuticals Inc
- Product quantity
- 274, 110 patches
- Reason for recall
- Defective Delivery System: customer complaints exceeded respective action limits.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3
- Distribution pattern
- Nationwide to the U.S. Market
- Recall initiation date
- May 6, 2022
- Initial firm notification
- Letter
- Center classification date
- May 20, 2022